204 related articles for article (PubMed ID: 23874819)
1. Postoperative chemoradiotherapy versus postoperative chemotherapy for completely resected gastric cancer with D2 Lymphadenectomy: a meta-analysis.
Huang YY; Yang Q; Zhou SW; Wei Y; Chen YX; Xie DR; Zhang B
PLoS One; 2013; 8(7):e68939. PubMed ID: 23874819
[TBL] [Abstract][Full Text] [Related]
2. Postoperative chemoradiotherapy versus chemotherapy for R0 resected gastric cancer with D2 lymph node dissection: an up-to-date meta-analysis.
Zhou ML; Kang M; Li GC; Guo XM; Zhang Z
World J Surg Oncol; 2016 Aug; 14(1):209. PubMed ID: 27502921
[TBL] [Abstract][Full Text] [Related]
3. Phase III Trial to Compare Adjuvant Chemotherapy With Capecitabine and Cisplatin Versus Concurrent Chemoradiotherapy in Gastric Cancer: Final Report of the Adjuvant Chemoradiotherapy in Stomach Tumors Trial, Including Survival and Subset Analyses.
Park SH; Sohn TS; Lee J; Lim DH; Hong ME; Kim KM; Sohn I; Jung SH; Choi MG; Lee JH; Bae JM; Kim S; Kim ST; Park JO; Park YS; Lim HY; Kang WK
J Clin Oncol; 2015 Oct; 33(28):3130-6. PubMed ID: 25559811
[TBL] [Abstract][Full Text] [Related]
4. Indirect comparison showed survival benefit from adjuvant chemoradiotherapy in completely resected gastric cancer with d2 lymphadenectomy.
Yang Q; Wei Y; Chen YX; Zhou SW; Jiang ZM; Xie DR
Gastroenterol Res Pract; 2013; 2013():634929. PubMed ID: 24194750
[TBL] [Abstract][Full Text] [Related]
5. D2-resected stage IIIc gastric cancer patients benefit from adjuvant chemoradiotherapy.
Peng J; Wei Y; Zhou F; Dai J; Zhong Y; Xie C; Qin Y; Gong J; Xiong B; Zhou Y
Cancer Med; 2016 Oct; 5(10):2773-2780. PubMed ID: 27666138
[TBL] [Abstract][Full Text] [Related]
6. Is postoperative adjuvant chemoradiotherapy efficacious and safe for gastric cancer patients with D2 lymphadenectomy? A meta-analysis of the literature.
Liang JW; Zheng ZC; Yu T; Wang X; Zhang JJ
Eur J Surg Oncol; 2014 Dec; 40(12):1614-21. PubMed ID: 24813809
[TBL] [Abstract][Full Text] [Related]
7. Lymphadenectomy extent and survival of patients with gastric carcinoma: a systematic review and meta-analysis of time-to-event data from randomized trials.
Mocellin S; Nitti D
Cancer Treat Rev; 2015 May; 41(5):448-54. PubMed ID: 25814393
[TBL] [Abstract][Full Text] [Related]
8. Age as a modifier of the effects of chemoradiotherapy with infusional 5-fluorouracil after D2 dissection in gastric cancer.
Wu HC; Lin WL; Lin CL; Lin CY; Chen SW; Chen YX; Chen CH; Lee SW; Chen SH; Tsao CJ; Huang WT; Guo HR
Aging (Albany NY); 2021 Jul; 13(13):17337-17348. PubMed ID: 34226296
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant chemoradiation versus chemotherapy for stage III gastric cancer after surgery with curative intent.
Turanli S; Atalay C; Berberoglu U; Gulben K
J Cancer Res Ther; 2015; 11(2):369-74. PubMed ID: 26148602
[TBL] [Abstract][Full Text] [Related]
10. Effect of adjuvant chemoradiotherapy on overall survival of gastric cancer patients submitted to D2 lymphadenectomy.
Jácome AA; Wohnrath DR; Scapulatempo Neto C; Fregnani JH; Quinto AL; Oliveira AT; Vazquez VL; Fava G; Martinez EZ; Santos JS
Gastric Cancer; 2013 Apr; 16(2):233-8. PubMed ID: 22740060
[TBL] [Abstract][Full Text] [Related]
11. Combination or single-agent chemotherapy as adjuvant treatment of gastric cancer: A systematic review and meta-analysis of published trials.
Iacovelli R; Pietrantonio F; Maggi C; de Braud F; Di Bartolomeo M
Crit Rev Oncol Hematol; 2016 Feb; 98():24-8. PubMed ID: 26481953
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant radiochemotherapy vs. chemotherapy alone in gastric cancer: a meta-analysis.
Matuschek C; Haussmann J; Bölke E; Tamaskovics B; Djiepmo Njanang FJ; Orth K; Peiper M; Gerber PA; Anooshar B; Kammers K; Budach W
Strahlenther Onkol; 2019 Aug; 195(8):695-706. PubMed ID: 30796495
[TBL] [Abstract][Full Text] [Related]
13. Comparative effectiveness of preoperative, postoperative and perioperative treatments for resectable gastric cancer: A network meta-analysis of the literature from the past 20 years.
Cai Z; Yin Y; Shen C; Wang J; Yin X; Chen Z; Zhou Y; Zhang B
Surg Oncol; 2018 Sep; 27(3):563-574. PubMed ID: 30217320
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant chemoradiotherapy after d2-lymphadenectomy for gastric cancer: the role of n-ratio in patient selection. results of a single cancer center.
Costa WL; Coimbra FJ; Fogaroli RC; Ribeiro HS; Diniz AL; Begnami MD; Mello CA; Fanelli MF; Silva MJ; Fregnani JH; Montagnini AL
Radiat Oncol; 2012 Oct; 7():169. PubMed ID: 23068190
[TBL] [Abstract][Full Text] [Related]
15. Phase III trial comparing capecitabine plus cisplatin versus capecitabine plus cisplatin with concurrent capecitabine radiotherapy in completely resected gastric cancer with D2 lymph node dissection: the ARTIST trial.
Lee J; Lim DH; Kim S; Park SH; Park JO; Park YS; Lim HY; Choi MG; Sohn TS; Noh JH; Bae JM; Ahn YC; Sohn I; Jung SH; Park CK; Kim KM; Kang WK
J Clin Oncol; 2012 Jan; 30(3):268-73. PubMed ID: 22184384
[TBL] [Abstract][Full Text] [Related]
16. [Safety and efficacy of adjuvant chemotherapy with oxaliplatin and S-1 for patients with locally advanced gastric cancer after D2 lymph nodes dissection].
Bao YD; Zhang H; Dong L; Jiang KW; Ye YJ; Wang S; Zhou J
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):145-152. PubMed ID: 33508920
[No Abstract] [Full Text] [Related]
17. Impact of the extent of surgery and postoperative chemoradiotherapy on recurrence patterns in gastric cancer.
Dikken JL; Jansen EP; Cats A; Bakker B; Hartgrink HH; Kranenbarg EM; Boot H; Putter H; Peeters KC; van de Velde CJ; Verheij M
J Clin Oncol; 2010 May; 28(14):2430-6. PubMed ID: 20368551
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of adjuvant chemoradiotherapy after a radical gastrectomy and a D2 node dissection for gastric adenocarcinoma.
Leong CN; Chung HT; Lee KM; Shakespeare TP; Mukherjee RK; Wong LC; Lu JJ; Tey J; Lim R; So JB; Back MF
Cancer J; 2008; 14(4):269-75. PubMed ID: 18677137
[TBL] [Abstract][Full Text] [Related]
19. Effect of Chemoradiotherapy on the Survival of Resectable Gastric Cancer Patients: A Systematic Review and Meta-Analysis.
Lu H; Sun Y; Zhu Z; Yao J; Xu H; Huang R; Huang B
Ann Surg Oncol; 2022 Oct; 29(11):6962-6975. PubMed ID: 35723792
[TBL] [Abstract][Full Text] [Related]
20. [Adjuvant chemo radiotherapy after gastrectomy and D2 lymphadenectomy in patients with gastric cancer in the National Institute of Cancer, Lima, Peru].
Montenegro P; Flores L; Quintana S; Casanova L; Ruíz E; León J; Mantilla R
Rev Gastroenterol Peru; 2013; 33(1):34-8. PubMed ID: 23539054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
